Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-13

Clinical Trial Update: Desensitising Celiac Disease Patients With the Human Hookworm [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating desensitisation of celiac disease patients using human hookworm; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Necator americanus (human hookworm) therapy (Necator americanus)

Snippet

Sponsor: The Prince Charles Hospital | Conditions: Celiac Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-10-13